Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ArtemLada
    Junior Member
    • Oct 2010
    • 3

    #1

    Less SNVs with larger interval file - MuTect

    Hi,
    I've used MuTect to call variants on .bam files (standard procedure for exome seq, tumor vs normal) using two different interval files (both from Illumina website): Nextera Exome Capture and Nextera Exome Capture Expanded. These intervals correspond to different kit versions, with expanded kit spanning about twice more targeted regions (~60Mb vs ~30Mb). The libraries has been created using Expanded kit.
    To my surprise, providing with 30Mb interval file resulted in 674 SNVs; same bam/MuTect parameters with 60Mb interval file gave 545 SNVs (here I refer to KEEP SNVs; total SNVs are also decreased when larger interval file is used).
    I am going to study how these sets overlap, but anyway I cannot understand this. Even if no more additional mutations is present in regions from larger interval file as compared to smaller one, still reduction to over 100 SNV (129) seems too large. I just cant trust my data analysis when I see such things.
    Did anybody experienced similar before?
    Thanks,
    Artem

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 07:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...